Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL465616 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL11247031 | 0.90 | — | — | |
| Ethylene SCHEMBL2488792 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL8012629 | 0.90 | — | — | |
| SCHEMBL8981852 | 0.90 | — | — | |
| Butadiene SCHEMBL10734664 | 0.88 | LMNA (0.44) | LMNAALOX15HSD17B10TSHRALDH1A1 | |
| Bicarbonate SCHEMBL28290875 | 0.88 | LMNA (0.44) | LMNAALOX15HSD17B10TSHRALDH1A1 | |
| Acetic Acid SCHEMBL8893677 | 0.85 | ALDH1A1 (0.47) | LMNAALOX15HSD17B10TSHRALDH1A1 | |
| Vinyl Chloride SCHEMBL27606793 | 0.85 | LMNA (0.42) | LMNAALOX15HSD17B10TSHRALDH1A1 | |
| SCHEMBL28369427 | 0.80 | ALDH1A1 (0.43) | LMNAALOX15HSD17B10TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2134651-B1 | ADDITIVE-CONTAINING ANIONIC CLAYS FOR REDUCING SOX EMISSIONS FROM AN FCC REGENERATOR AND PROCESS FOR MAKING THEM | ALBEMARLE NETHERLANDS BV (NL) | 2018-02-14 | — | — | EP | disclosed |
| US-20170296674-A1 | GUM RESIN AS A CARRIER FOR TOPICAL APPLICATION OF PHARMACOLOGICALLY ACTIVE AGENTS | JALEVA PHARMACEUTICALS, LLC (US) | 2017-10-19 | — | — | US | disclosed |
| US-9554984-B2 | Oral care compositions for topical application | JALEVA PHARMACEUTICALS, LLC (US) | 2017-01-31 | — | — | US | disclosed |
| US-20150051200-A1 | GUM RESIN AS A CARRIER FOR TOPICAL APPLICATION OF PHARMACOLOGICALLY ACTIVE AGENTS | JALEVA PHARMACEUTICALS, LLC (US) | 2015-02-19 | — | — | US | disclosed |
| US-8846092-B2 | Gum resin as a carrier for topical application of pharmacologically active agents | JALEVA PHARMACEUTICALS, LLC (US) | 2014-09-30 | — | — | US | disclosed |
| US-8709439-B2 | Film-forming resins as a carrier for topical application of pharmacologically active agents | JALEVA PHARMACEUTICALS, LLC (US) | 2014-04-29 | — | — | US | disclosed |
| US-8648082-B2 | Gum resin as a carrier for topical application of antimicrobial agents | JALEVA, LLC (US) | 2014-02-11 | — | — | US | disclosed |
| US-20120258164-A1 | TRANSDERMAL GRANISETRON | STRAKAN INTERNATIONAL LIMITED | 2012-10-11 | — | — | US | disclosed |
| US-20120220578-A1 | GUM RESIN AS A CARRIER FOR TOPICAL APPLICATION OF PHARMACOLOGICALLY ACTIVE AGENTS | JALEVA, LLC | 2012-08-30 | — | — | US | disclosed |
| EP-1761332-B1 | PROCESS FOR THE PREPARATION OF AN ADDITIVE-CONTAINING ANIONIC CLAY | ALBEMARLE NETHERLANDS BV (NL) | 2010-09-01 | — | — | EP | disclosed |
| EP-1761332-A1 | PROCESS FOR THE PREPARATION OF AN ADDITIVE-CONTAINING ANIONIC CLAY | Albemarle Netherlands B.V. (NL) | 2007-03-14 | — | — | EP | disclosed |
| EP-1745849-A1 | Process for preparing a metal-containing composition comprising a PH-dependent anion | Albemarle Netherlands B.V. (NL) | 2007-01-24 | — | — | EP | disclosed |
| EP-1740502-A1 | PROCESS FOR THE PREPARATION OF AN ADDITIVE-CONTAINING ANIONIC CLAY | Albemarle Netherlands B.V. (NL) | 2007-01-10 | — | — | EP | disclosed |
| US-20060177493-A1 | Transdermal granisetron | STRAKAN LIMITED (GB) | 2006-08-10 | — | — | US | disclosed |
| WO-2005102514-A1 | PROCESS FOR THE PREPARATION OF A METAL-CONTAINING COMPOSITION | ALBEMARLE NETHERLANDS B.V. (NL) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005102930-A1 | PROCESS FOR THE PREPARATION OF AN ADDITIVE-CONTAINING ANIONIC CLAY | ALBEMARLE NETHERLANDS B.V. (NL) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005102515-A1 | PROCESS FOR THE PREPARATION OF AN ADDITIVE-CONTAINING ANIONIC CLAY | ALBEMARLE NETHERLANDS B.V. (NL) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005058484-A1 | CATALYST COMPOSITION COMPRISING ANIONIC CLAY AND RARE EARTH METALS, ITS PREPARATION AND USE IN FCC | ALBEMARLE NETHERLANDS B.V. (NL) | 2005-06-30 | — | — | WO | disclosed |
| US-20050095208-A1 | Biological dressing comprised of gum resin, volatile solvent and oral care agent; drys to form coating that sticks to skin, mucosa, teeth and tissue areas for sustained release; hygiene and whitening | TRIFECTA THERAPEUTICS LLC | 2005-05-05 | — | — | US | disclosed |
| US-20030068331-A1 | Dressing for treatment of a dermatological disease comprised of a gum resin, a topically acceptable volatile solvent, and a pharmacologically active agent | TRIFECTA THERAPEUTICS LLC | 2003-04-10 | — | — | US | disclosed |